Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort.

[1]  C. Roehrborn,et al.  Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia. , 2010, Urology.

[2]  R. Roberts,et al.  Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia. , 2003, American journal of epidemiology.

[3]  R. Bruskewitz.  Management of Symptomatic BPH in the US: Who Is Treated and How? , 1999, European Urology.

[4]  D. Jacobson,et al.  LONG-TERM LONGITUDINAL CHANGES IN SERUM PSA IN A COMMUNITY-BASED COHORT OF MEN , 1999 .

[5]  R. Roberts,et al.  Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old. , 1999, The Journal of urology.

[6]  P. Boyle,et al.  Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. , 1999, Urology.

[7]  R. Roberts,et al.  Natural history of prostatism: risk factors for acute urinary retention. , 1997, The Journal of urology.

[8]  J. Oesterling,et al.  Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. , 1996, The Journal of urology.

[9]  C G Chute,et al.  Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. , 1995, The Journal of urology.

[10]  J. Oesterling,et al.  New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States. , 1995, Archives of internal medicine.

[11]  W. Hop,et al.  Parameters of prostate volume and shape in a community based population of men 55 to 74 years old. , 1994, The Journal of urology.

[12]  C G Chute,et al.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. , 1993, JAMA.

[13]  A T Cockett,et al.  Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. , 1993, The Journal of urology.

[14]  J. Oesterling,et al.  A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men. , 1993, Archives of family medicine.

[15]  G N Collins,et al.  Relationship between prostate specific antigen, prostate volume and age in the benign prostate. , 1993, British journal of urology.

[16]  J. Oesterling,et al.  Validation of a new quality of life questionnaire for benign prostatic hyperplasia. , 1992, Journal of clinical epidemiology.

[17]  H. Feldman,et al.  Families of lines: random effects in linear regression analysis. , 1988, Journal of applied physiology.

[18]  J. Ware.  Linear Models for the Analysis of Longitudinal Studies , 1985 .

[19]  R. Roberts,et al.  Longitudinal changes in peak urinary flow rates in a community based cohort. , 2000, The Journal of urology.

[20]  M. Emmert-Buck,et al.  Long term organ culture of human prostate tissue in a NASA-designed rotating wall bioreactor. , 1999, The Journal of urology.